Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Studies with 17. beta. (16. cap alpha. -(/sup 125/I)iodo)-estradiol, an estrogen receptor-binding radiopharmaceutical, in rats bearing mammary tumors

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:6354921
We have studied the distribution of 17..beta..(16..cap alpha..-(/sup 125/I)iodo)-estradiol (I-E/sub 2/) in tumor-bearing and normal rats. High early adrenal-to-blood ratios (up to 22 at 5 min) were seen in all groups, but this fell to six at 1 h. Uterus-to-blood ratios of 15 were found, and these were fairly constant up to 2 h after administration. Uptake of label in the uterus, but not in the adrenals, was sensitive to excess diethylstilbestrol, which competes with I-E/sub 2/ for estrogen receptors. Mean tumor-to-blood ratios of 1.4, 5.5, 8.7 were seen at 1 h in rats with transplanted, spontaneous, and N-nitrosomethylurea-induced tumors, respectively. Better estrongen-receptor-binding radiopharmaceuticals can probably be designed.
Research Organization:
Univ. of Wisconsin Hospital, Madison
OSTI ID:
6354921
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 22:5; ISSN JNMEA
Country of Publication:
United States
Language:
English

Similar Records

Studies with 17 beta(16 alpha-(/sup 125/I)iodo)-estradiol, an estrogen receptor-binding radiopharmaceutical, in rats bearing mammary tumors
Journal Article · Fri May 01 00:00:00 EDT 1981 · J. Nucl. Med.; (United States) · OSTI ID:5578454

Receptor-binding radiopharmaceuticals for imaging breast tumors: estrogen-receptor interactions and selectivity of tissue uptake of halogenated estrogen analogs
Conference · Sun Jun 01 00:00:00 EDT 1980 · J. Nucl. Med.; (United States) · OSTI ID:5298972

E-17 alpha(/sup 125/I)iodovinylestradiol: an estrogen-receptor-seeking radiopharmaceutical
Journal Article · Sat May 01 00:00:00 EDT 1982 · J. Nucl. Med.; (United States) · OSTI ID:6879760